Streamline the industrial development chain to support the fast track of innovation

The research team inquired in detail about the company's production scale, product types, and sales markets, conducted an on-site inspection of the production line, and understood the company's needs and R&D innovation status. The team aimed to refine the company's technological needs, sort out common and key technical issues in the industry, encourage the company to maintain its dedication to the biopharmaceutical field, remain committed to innovation, strive for excellence, enhance scientific research and independent innovation capabilities, strengthen product quality assurance, continuously improve the company's core competitiveness, and strive to win a larger market. At the same time, they pointed out some challenges and difficulties currently faced by the company. They emphasized that the company should increase investment in biopharmaceutical R&D, continuously enhance industrial upgrading and core competitiveness, and promote the agglomeration development of the biopharmaceutical industry through the leading and exemplary role of Jiangxi's biopharmaceutical sector, thereby promoting high-quality development of the industry.

The General Manager stated that this research activity will guide the company to continue adhering to innovation-driven development without relaxation, further enhance the company's confidence in implementing Jiangxi Province's "1269" action plan and the "Six Major Actions for Science and Technology Revitalization of Jiangxi (2023-2025)" goals, expand and strengthen the biopharmaceutical industry development chain, and jointly promote the rapid development of Jiangxi's biopharmaceutical industry.